Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDimmatics biotechnologies GmbH Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/17/2025 | Q3 2025 | N/A | -$0.42 | N/A | N/A | $5.19 M |
| 08/13/2025 | Q2 2025 | N/A | -$0.58 | N/A | N/A | $4.74 M |
| 05/13/2025 | Q1 2025 | -$0.29 | -$0.33 | -0.04 | N/A | $18.58 M |
| 03/27/2025 | Q4 2024 | -$0.31 | $0.46 | 0.77 | N/A | $56.25 M |
| 11/18/2024 | Q3 2024 | -$0.28 | -$0.08 | 0.2 | N/A | $50.56 M |
| 08/13/2024 | Q2 2024 | -$0.30 | -$0.17 | 0.13 | N/A | $18.76 M |
| 05/14/2024 | Q1 2024 | -$0.22 | -$0.03 | 0.19 | N/A | $30.45 M |
| 03/21/2024 | Q4 2023 | -$0.35 | -$0.31 | 0.04 | N/A | $15.92 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.32 | N/A | N/A | $5.93 M |
| 06/30/2023 | Q2 2023 | -$0.27 | -$0.32 | -0.05 | N/A | $22.35 M |
| 05/16/2023 | Q1 2023 | N/A | -$0.20 | N/A | N/A | $9.80 M |
| 03/22/2023 | Q4 2022 | N/A | -$0.19 | N/A | N/A | $37.65 M |
| 11/17/2022 | Q3 2022 | N/A | -$0.32 | N/A | N/A | $15.06 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.22 | N/A | N/A | $17.22 M |
| 06/02/2022 | Q1 2022 | N/A | $1.36 | N/A | N/A | $102.91 M |
| 12/31/2021 | Q4 2021 | N/A | -$0.27 | N/A | N/A | $15.73 M |
| 11/16/2021 | Q3 2021 | N/A | -$0.43 | N/A | N/A | $6.44 M |
| 06/30/2021 | Q2 2021 | N/A | -$0.38 | N/A | N/A | $5.19 M |
| 05/18/2021 | Q1 2021 | N/A | -$0.34 | N/A | N/A | $7.40 M |
| 12/31/2020 | Q4 2020 | N/A | -$0.36 | N/A | N/A | $9.45 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
immatics biotechnologies GmbH Earnings: FAQ's
immatics biotechnologies GmbH has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based offlast year's report dates.
The conference call for immatics biotechnologies GmbH's latest earnings report can be listened to online.
The conference call transcript for immatics biotechnologies GmbH's latest earnings report can be read online.
immatics biotechnologies GmbH (:IMTXW) has a recorded annual revenue of $155.84 M.
immatics biotechnologies GmbH (:IMTXW) has a recorded net income of $15.22 M.immatics biotechnologies GmbH has generated $0.14 earnings per share over the last four quarters.
immatics biotechnologies GmbH (:IMTXW) has a price-to-earnings ratio of -9.01 and price/earnings-to-growth ratio is 0.14.